Association of Inhibin B Serum Levels with Parameters of Follicular Response in a Randomized Controlled Trial Comparing GnRH Agonist Versus Antagonist Protocols for Ovarian Hyperstimulation

[1] Findlay JK(1993)An update on the roles of inhibin, activin, and follistatin as local regulators of folliculogenesis Biol Reprod 48 15-23

[2] Groome NP(1996)Measurement of dimeric inhibin B throughout the human menstrual cycle J Clin Endocrinol Metab 81 1401-1405

[3] Illingworth PJ(1999)Inhibin Aand inhibin B reflect ovarian function in assisted reproduction but are less useful at predicting outcome Hum Reprod 14 409-415

[4] O'Brien M(2000)Relationship between serum in-hibin A and B and ovarian follicle development after a daily fixed dose administration of recombinant follicle-stimulating hormone J Clin Endocrinol Metab 85 607-613

[5] Pai R(2001)Ovarian reserve testing and the use of prognostic models in patients with subfertility Hum Reprod Update 7 581-590

[6] Rodger FE(1996)Circulating inhibins and activin A during GnRH-analogue down-regulation and ovarian hyperstimulation with recombinant FSH for in-vitro fertilization-embryo transfer Clin Endocrinol (Oxf) 45 741-748

[7] Mather JP(2001)Concentra-tions of inhibins and activin in women undergoing stimulation with recombinant follicle-stimulating hormone for in vitro fer-tilization treatment Fertil Steril 75 32-37

[8] McNeilly AS(2000)Ovarian stimulation with HMG: Results of a prospective randomized phase III Euro-pean study comparing the luteinizing hormone-releasing hor-mone (LHRH)-antagonist cetrorelix and the LHRH-agonist buserelin. European Cetrorelix Study Group Hum Reprod 15 526-531

[9] Hall JE(2000)Treatment with the gonadotrophin-releasing hormone antagonist ganirelix in women undergoing ovarian stimulation with recombinant follicle stimulating hor-mone is effective, safe and convenient: Results of a controlled, randomized, multicentre trial The European Orgalutran Study Group. Hum Reprod 15 1490-1498

[10] Welt CK(2001)Comparable clinical outcome using the GnRH antagonist ganirelix or a long protocol of the GnRH agonist triptorelin for the pre-vention of premature LH surges in women undergoing ovarian stimulation Hum Reprod 16 644-651

[1] Findlay JK(1993)An update on the roles of inhibin, activin, and follistatin as local regulators of folliculogenesis Biol Reprod 48 15-23

[2] Groome NP(1996)Measurement of dimeric inhibin B throughout the human menstrual cycle J Clin Endocrinol Metab 81 1401-1405

[3] Illingworth PJ(1999)Inhibin Aand inhibin B reflect ovarian function in assisted reproduction but are less useful at predicting outcome Hum Reprod 14 409-415

[4] O'Brien M(2000)Relationship between serum in-hibin A and B and ovarian follicle development after a daily fixed dose administration of recombinant follicle-stimulating hormone J Clin Endocrinol Metab 85 607-613

[5] Pai R(2001)Ovarian reserve testing and the use of prognostic models in patients with subfertility Hum Reprod Update 7 581-590

[6] Rodger FE(1996)Circulating inhibins and activin A during GnRH-analogue down-regulation and ovarian hyperstimulation with recombinant FSH for in-vitro fertilization-embryo transfer Clin Endocrinol (Oxf) 45 741-748

[7] Mather JP(2001)Concentra-tions of inhibins and activin in women undergoing stimulation with recombinant follicle-stimulating hormone for in vitro fer-tilization treatment Fertil Steril 75 32-37

[8] McNeilly AS(2000)Ovarian stimulation with HMG: Results of a prospective randomized phase III Euro-pean study comparing the luteinizing hormone-releasing hor-mone (LHRH)-antagonist cetrorelix and the LHRH-agonist buserelin. European Cetrorelix Study Group Hum Reprod 15 526-531

[9] Hall JE(2000)Treatment with the gonadotrophin-releasing hormone antagonist ganirelix in women undergoing ovarian stimulation with recombinant follicle stimulating hor-mone is effective, safe and convenient: Results of a controlled, randomized, multicentre trial The European Orgalutran Study Group. Hum Reprod 15 1490-1498

[10] Welt CK(2001)Comparable clinical outcome using the GnRH antagonist ganirelix or a long protocol of the GnRH agonist triptorelin for the pre-vention of premature LH surges in women undergoing ovarian stimulation Hum Reprod 16 644-651